Common polymorphisms in critical genes of innate immunity do not contribute to the risk for chronic disseminated candidiasis in adult leukemia patients

References

• Anttila VJ, Elonen E, Nordling S, et al. Hepatosplenic candidiasis in patients with acute leukemia: incidence and prognostic implications. Clin Infect Dis 1997; 24: 375–380
   PubMed Web of Science ®Google Scholar
• Thaler M, Pastakia B, Shawker TH, O'Leary T, Pizzo PA. Hepatic candidiasis in cancer patients: the evolving picture of the syndrome. Ann Intern Med 1988; 108: 88–100
   PubMed Web of Science ®Google Scholar
• Walsh TJ, Whitcomb PO, Revankar SG, Pizzo PA. Successful treatment of hepatosplenic candidiasis through repeated cycles of chemotherapy and neutropenia. Cancer 1995; 76: 2357–2362
   PubMedGoogle Scholar
• Mencacci A, Del Sero G, Cenci E, et al. Endogenous interleukin 4 is required for development of protective CD4+ T helper type 1 cell responses to Candida albicans. J Exp Med 1998; 187: 307–317
   PubMed Web of Science ®Google Scholar
• Romani L. Immunity to Candida albicans: Th1, Th2 cells and beyond. Curr Opin Microbiol 1999; 2: 363–367
   PubMed Web of Science ®Google Scholar
• Cenci E, Romani L, Mencacci A, et al. Interleukin-4 and interleukin-10 inhibit nitric oxide-dependent macrophage killing of Candida albicans. Eur J Immunol 1993; 23: 1034–1038
   PubMed Web of Science ®Google Scholar
• Romani L, Mencacci A, Grohmann U, et al. Neutralizing antibody to interleukin 4 induces systemic protection and T helper type 1-associated immunity in murine candidiasis. J Exp Med 1992; 176: 19–25
   PubMed Web of Science ®Google Scholar
• Romani L, Puccetti P, Mencacci A, et al. Neutralization of IL-10 up-regulates nitric oxide production and protects susceptible mice from challenge with Candida albicans. J Immunol 1994; 152: 3514–3521
   PubMed Web of Science ®Google Scholar
• Letterio JJ, Lehrnbecher T, Pollack G, Walsh TJ, Chanock SJ. Invasive candidiasis stimulates hepatocyte and monocyte production of active transforming growth factor beta. Infect Immun 2001; 69: 5115–5120
   PubMed Web of Science ®Google Scholar
• Roilides E, Sein T, Schaufele R, Chanock SJ, Walsh TJ. Increased serum concentrations of interleukin-10 in patients with hepatosplenic candidiasis. J Infect Dis 1998; 178: 589–592
   PubMedGoogle Scholar
• Choi EH, Foster CB, Taylor JG, et al. Association between chronic disseminated candidiasis in adult acute leukemia and common IL4 promoter haplotypes. J Infect Dis 2003; 187: 1153–1156
   PubMed Web of Science ®Google Scholar
• Puccetti P, Romani L, Bistoni F. A TH1-TH2-like switch in candidiasis: new perspectives for therapy. Trends Microbiol 1995; 3: 237–240
   PubMed Web of Science ®Google Scholar
• Roilides E, Lyman CA, Panagopoulou P, Chanock S. Immunomodulation of invasive fungal infections. Infect Dis Clin North Am 2003; 17: 193–219
   PubMed Web of Science ®Google Scholar
• Foster CB, Lehrnbecher T, Mol F, et al. Host defense molecule polymorphisms influence the risk for immune-mediated complications in chronic granulomatous disease. J Clin Invest 1998; 102: 2146–2155
   PubMed Web of Science ®Google Scholar
• Foster CB, Chanock SJ. Mining variations in genes of innate and phagocytic immunity: current status and future prospects. Curr Opin Hematol 2000; 7: 9–15
   PubMedGoogle Scholar
• Lehrnbecher T, Foster C, Vazquez N, Mackall CL, Chanock SJ. Therapy-induced alterations in host defense in children receiving therapy for cancer. J Pediatr Hematol Oncol 1997; 19: 399–417
   PubMed Web of Science ®Google Scholar
• Choi EH, Zimmerman PA, Foster CB, et al. Genetic polymorphisms in molecules of innate immunity and susceptibility to infection with Wuchereria bancrofti in South India. Genes Immun 2001; 2: 248–253
   PubMedGoogle Scholar
• Lehrnbecher T, Foster CB, Zhu S, et al. Variant genotypes of the low-affinity Fcgamma receptors in two control populations and a review of low-affinity Fcgamma receptor polymorphisms in control and disease populations. Blood 1999; 94: 4220–4232
   PubMed Web of Science ®Google Scholar
• Garred P, Pressler T, Madsen HO, et al. Association of mannose-binding lectin gene heterogeneity with severity of lung disease and survival in cystic fibrosis. J Clin Invest 1999; 104: 431–437
   PubMedGoogle Scholar
• Garred P, Madsen HO, Halberg P, et al. Mannose-binding lectin polymorphisms and susceptibility to infection in systemic lupus erythematosus. Arthritis Rheum 1999; 42: 2145–2152
   PubMed Web of Science ®Google Scholar
• Boot RG, Renkema GH, Verhoek M, et al. The human chitotriosidase gene. Nature of inherited enzyme deficiency. J Biol Chem 1998; 273: 25680–25685
   PubMed Web of Science ®Google Scholar
• Chanock S. Candidate genes and single nucleotide polymorphisms (SNPs) in the study of human disease. Dis Markers 2001; 17: 89–98
   PubMed Web of Science ®Google Scholar
• Taylor JG, Choi EH, Foster CB, Chanock SJ. Using genetic variation to study human disease. Trends Mol Med 2001; 7: 507–512
   PubMed Web of Science ®Google Scholar